All In Biotech

Drug Trial Radar · NCT06978725

A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis

A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Cutaneous Sarcoidosis

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 168 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

168

Planned (sponsor's estimate)

Start

Apr 9, 2025

Primary completion

Dec 31, 2028

Study completion Dec 31, 2029

Sponsor

Lead sponsor
Priovant Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
May 18, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.

Conditions

  • Cutaneous Sarcoidosis

Interventions

  • Oral BrepocitinibDrug

    Oral Brepocitinib

  • Oral PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part 1: Number of participants with Treatment Emergent Adverse Events and Serious Adverse Events as assessed by CTCAE v5.0Time frame: Week 16
  2. Part 2: Proportion of participants achieving a reduction in Cutaneous Sarcoidosis Activity and Morphology Instrument Activity (CSAMI-A) from baseline to Week 16.Time frame: 16 Weeks

Locations

44 sites in 3 countries. Site status is shown where the registry gives one.

  • Clinical Trial Site

    Birmingham, Alabama · Recruiting

  • Clinical Trial Site

    Phoenix, Arizona · Recruiting

  • Clinical Trial Site

    Tucson, Arizona · Recruiting

  • Clinical Trial Site

    San Francisco, California · Recruiting

  • Clinical Trial Site

    New Haven, Connecticut · Recruiting

  • Clinical Trial Site

    Washington D.C., District of Columbia · Recruiting

  • Clinical Trial Site

    Atlanta, Georgia · Recruiting

  • Clinical Trial Site

    Sandy Springs, Georgia · Recruiting

  • Clinical Trial Site

    Chicago, Illinois · Recruiting

  • Clinical Trial Site

    Chicago, Illinois · Recruiting

  • Clinical Trial Site

    Kansas City, Kansas · Recruiting

  • Clinical Trial Site

    Louisville, Kentucky · Recruiting

  • Clinical Trial Site

    New Orleans, Louisiana · Recruiting

  • Clinical Trial Site

    Baltimore, Maryland · Recruiting

  • Clinical Trial Site

    Boston, Massachusetts · Recruiting

  • Clinical Trial Site

    Ann Arbor, Michigan · Recruiting

  • Clinical Trial Site

    Ann Arbor, Michigan · Recruiting

  • Clinical Trial Site

    Troy, Michigan · Recruiting

  • Clinical Trial Site

    St Louis, Missouri · Recruiting

  • Clinical Trial Site

    Lebanon, New Hampshire · Recruiting

  • Clinical Trial Site

    Brooklyn, New York · Recruiting

  • Clinical Trial Site

    Lake Success, New York · Recruiting

  • Clinical Trial Site

    New York, New York · Recruiting

  • Clinical Trial Site

    New York, New York · Recruiting

  • Clinical Trial Site

    Rochester, New York · Recruiting

  • Clinical Trial Site

    Chapel Hill, North Carolina · Recruiting

  • Clinical Trial Site

    Durham, North Carolina · Recruiting

  • Clinical Trial Site

    Greenville, North Carolina · Recruiting

  • Clinical Trial Site

    Cleveland, Ohio · Recruiting

  • Clinical Trial Site

    Fairborn, Ohio · Recruiting

  • Clinical Trial Site

    Hershey, Pennsylvania · Recruiting

  • Clinical Trial Site

    Philadelphia, Pennsylvania · Recruiting

  • Clinical Trial Site

    Philadelphia, Pennsylvania · Recruiting

  • Clinical Trial Site

    Charleston, South Carolina · Recruiting

  • Clinical Trial Site

    Houston, Texas · Recruiting

  • Clinical Trial Site

    Norfolk, Virginia · Recruiting

  • Clinical Trial Site

    Richmond, Virginia · Recruiting

  • Clinical Trial Site

    Madison, Wisconsin · Recruiting

  • Clinical Trial Site

    Milwaukee, Wisconsin · Recruiting

  • Clinical Trial Site

    Melbourne, Victoria, Australia · Recruiting

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.